Chicago, IL (PRWEB) September 30, 2014
NuMale Medical Center, a nationwide leader in mens sexual dysfunction and enhancement, announced today that its Chicago mens health clinic has exceeded expectations, treating men from diverse backgrounds, ages, and geographic areas. Since opening its doors in March of 2014, NuMales Chicago clinic has helped patients suffering from erectile dysfunction (ED), low libido, low testosterone (low-T), and many other medical issues.
Run by Medical Director Dr. Todd Arbiture, D.O., NuMale Medical Center has successfully treated thousands of patients from the Chicago area and all over the Midwest. NuMales unique, science-based approach to mens sexual dysfunction and enhancement has attracted patients of all ages and backgrounds who suffer from these conditions.
Each patient at NuMale Medical Center receives a confidential, comprehensive medical evaluation. After a thorough consultation, NuMales expert physicians create a custom-tailored action plan for each patient. This ensures that every individual receives the safest, most effective treatment possible for his medical history and specific needs.
NuMales industry-leading medical staff regularly helps patients suffering from premature ejaculation, low sex drive, and even hair loss. Using FDA-approved treatments, including the PriapusTM procedure, NuMales doctors achieve a 98 percent success rate in treating ED. This allows NuMale to offer a 100 percent money-back guarantee on ED consultations for new patients.
NuMales Chicago office has helped thousands of patients suffering from sexual dysfunction and other issues, said Medical Director Dr. Todd Arbiture, D.O. We have worked hard to create a comfortable environment for men to discuss these important health-related topics, and I am incredibly proud of the response we have seen. NuMales science-based approach sets us apart from other clinics, and we work every day to treat our patients overall well-being while restoring their confidence and improving their relationships.
NuMale Medical Center is located at 4711 Golf Rd #1050, Skokie, IL 60076. Conveniently located just off I-94 near the Westfield Old Orchard Mall, NuMales office features a no-waiting policy. For more information about NuMale, or to schedule an appointment, please call NuMale Medical Center at 847-354-4383 or visit http://www.numale.com
About NuMale Medical Center
NuMale Medical Center is a leading national provider of customized, comprehensive treatment for male sexual dysfunction and enhancement. NuMale helps men suffering from erectile dysfunction (ED), low testosterone (Low-T), premature ejaculation (PE) and low sex drive, utilizing a wide range of the most highly-respected, FDA-approved treatments and therapies including bio-identical hormone replacement and the Priapus shot. Founded and led by accomplished physician Dr. Christopher Asandra M.D., NuMale Medical Center has expanded rapidly in its first year, with six nationwide facilities and many more to come. Learn more at numale.com and follow the company on Facebook, Twitter and LinkedIn.
St. Louis, MO (PRWEB) October 28, 2014
Castlewood Eating Disorder Treatment Centers is pleased to announce its all-inclusive 2014 Holiday Intensive Treatment Program at all three of its locations around the nation. This flexible and convenient intensive program helps individuals with anorexia, bulimia, binge eating disorder, compulsive eating and other types of disordered eating issues connect with the recovery community and create a personal set of strategies for coping during the holiday season. A centralized intake number is available at 855.886.6098.
Due to the positive response from clients who took part last year, this years Holiday Intensive Program will be offered from November through January 2015. The extra month allows more flexibility for the 14 days (and sometimes more) necessary to benefit from this rigorous and intensive program.
According to Nicole Siegfried, PhD, CEDS, Clinical Director of Castlewood at The Highlands, there are several issues that are problematic for those with eating disorders during the holidays.
Social gatherings involving food are the most common problem areas, said Dr. Siegfried. Helping our clients think about past experiences that were difficult, or what they imagine will be hard even if they are in the early stages of recovery, is a starting point. From there we can work with them to identify ways to cope with their specific fears and concerns. Our intensive holiday program allows for these strategies to be not only developed, but practiced, in a safe, non-threatening environment.
Individuals ages 16 and older are eligible to participate in this all-inclusive day treatment program. Clients living out of town can enjoy residing in Castlewoods transitional housing. Peer support is an important aspect of recovery and living in recovery housing during the program provides positive therapeutic interaction. By concentrating on holiday issues and taking advantage of treatment during vacation from school, work and other commitments, it is possible for those struggling with eating disorders to make this important time of year an enjoyable experience.
Our Holiday Intensive Program offers extra support for those already in recovery, and creates a jump-start for those seeking help for the first time, said Nancy Albus, M.Ed., LPC, NCC, CEDS, who is both CEO of Castlewood in St. Louis and an experienced eating disorder therapist.
Clients can choose to participate at any of Castlewoods treatment centers. Castlewoods flagship center is located in St. Louis, The Highlands is in Birmingham, Ala., and Monarch Cove is located in Monterey, Calif. This day treatment option is open to men, women and adolescents. Clients will receive a fully individualized treatment plan, implemented by licensed therapists and registered dietitians.
For more information, contact the intake department at 855.886.6098. Castlewoods intake specialists can answer questions about the program, insurance coverage, and a special self-pay rate being offered for the Holiday Intensive Treatment Program.
Castlewood Treatment Center helps people with eating disorders transform to healthier lives. Established in 2000 as the first residential treatment facility in Missouri, Castlewoods licensed health care team is nationally recognized and has decades of combined experience in providing compassionate, professional and successful treatment for more than 1,000 men and women with eating disorders and related conditions. They offer individualized, supportive and comprehensive care in a home-like residential setting to help people towards recovery and a bright, healthy future. Castlewood facilities are located in St. Louis, Missouri; Monterey, California; and Birmingham, Alabama and are accredited by the Commission on Accreditation of Rehabilitation Facilities and The Joint Commission. For more information, visit castlewoodtc.com.
http://www.alphamaleclinics.com.au/Erectile Dysfunction Treatment testimonial from a satisfied client of Alpha Male Clinics. FREE ED consultation with male d…
Video Rating: 4 / 5
Gary Wilson explains how overstimulation via today’s Internet porn can lead to erectile dysfunction, delayed ejaculation, anorgasmia, loss of libido, and mor…
Video Rating: 4 / 5
Video Rating: 0 / 5
Albany, New York (PRWEB) September 24, 2014
The global erectile dysfunction drugs market was worth $ 4.3 billion in 2012. It is expected to decline at an aggregate rate of 4.5% between 2013 and 2019, which means the market will be valued at $ 3.4 billion in 2019.
All facts and figures have be provided through a research report titled Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 2019, published by Transparency Market Research.
To browse through the research report, or to view the ToC, please visit: http://www.transparencymarketresearch.com/erectile-dysfunction-drugs.html
The report showed that Viagra (sildenafil citrate) by Pfizer held 45% of the global erectile dysfunction drugs market in 2012. Its majority hold over the market is predicted to decline after patent exclusivity rights expire in 2013 in Europe and other countries. Cialis (tadalafil) held the second-largest market share with $ 1.9 billion in 2012. Its patent exclusivity will reportedly expire in 2017, supplementing the decline of the erectile dysfunction drugs market by 2019. The same is to be expected from Levitra/Staxyn (Vardenafil) by Bayer, whose patent exclusivity is set to expire in 2018. The report explains that once the patents expire, the market will be flooded with competitive generic drugs with similar chemical compositions, reducing the revenue generated by the major players in the market.
Factors that might improve the growth of the erectile dysfunction drugs market are the approval of the new promising drugs Zydena (udenafil) and Stendra/Spedra (avanafil) in mid 2014.
The report categorized the global erectile dysfunction market according to the product brands or pipeline analysis. By products, the report investigates Viagra, Cialis, Levitra/Staxyn, MUSE, Zydena, Mvix, and Helleva. By pipeline analysis, the report identifies Vitaros, Uprima, Gene therapy, Melanocortin Activators, and Topiglan.
For further inquiries, ask here: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1550
By geography, the research report identifies the regions of North America, Europe, Asia-Pacific, and Rest of the World. The North American region dominated the global erectile dysfunction drug market in revenue created. It is expected to maintain its dominance throughout the forecast period.
The key players explained in the report are Pfizer, GlaxoSmithKline, Bayer, Dong-A Pharmaceutical Corporation Limited, Eli Lilly And Company, Cristalia Produtos Quimicos Farmaceuticos Ltda., Vivus Incorporated, S.K. Chemicals Corporation Limited, Meda Pharmaceuticals, and Apricus Biosciences, Incorporated.
Erectile dysfunction is a male inability to generate and/or maintain penile erection, for the sake of a fully successful sexual intercourse. It primarily affects men above the age of 40. Typical causes of erectile dysfunction are diabetes and hypertension, along with a host of common habits attributed to a sedentary lifestyle, obesity, excessive consumption of alcohol, smoking, use of recreational drugs, and use of anti-depressants.
90 Sate Street, Suite 700
Albany, NY 12207
USA/Canada Toll Free: 866-552-3453
Causes of ED in Men Are More Varied than Previously Thought but can be …
According to Dr. Shteynshlyuger, "Low-intensity extracorporeal shockwave therapy for ED (ED-SWT) is the latest innovation in treatment of ED without pills. The MediSpec ED1000 penile shockwave treatment and Renova Linear Shockwave therapy for ED …
Read more on SYS-CON Media (press release)
Ed Woodward Gets the Hollywood Treatment for Manchester United Transfers
Woodward, United's executive vice-chairman, has been a polarising figure at United due to some recent transfer struggles and some high-profile whiffs. But after United's flurry of transfer activity, including a late swoop for superstar Falcao, it seems …
Read more on Bleacher Report
Pedophilia: A Disorder, Not a Crime
Without legal protection, a pedophile cannot risk seeking treatment or disclosing his status to anyone for support. He could lose his job, and future job prospects, if he is seen at a group-therapy session, asks for a reasonable accommodation to take …
Read more on New York Times
Chinese drug maker set to break foreign monopoly on anti-ED pill
This line from a poem by Xin Qiji , a famous poet in the Southern Song Dynasty (1127 – 1279), now has a new context in 21st century China . Now , a homegrown drug for erectile dysfunction ( ED ), known as gold dagger-axe , presents an option for …
Read more on People’s Daily Online
Viagra Increased Risk For Melanoma?
A delayed diagnosis of metastatic melanoma can mean rapid death. Men who use Viagra to get a rise in the bedroom may find that the little blue pill also may increase the risk of developing melanoma, the deadliest form of skin cancer. Recently medical …
Read more on Legal Examiner
EDF Renewable Energy to sell 57 MW of Californian solar project to Dominion
A fact of symptoms shall be benefited out of your treatment. levitra kopen zonder recept Crohn's reinforcement is associated with a impotence of 19th web known as new number. “We are glad to extend our relationship with Dominion having first worked …
Read more on EcoSeed
Bryan Bulaga Wants to Go Next Week
You can all breathe a huge sigh of relief. Green Bay Packers right tackle Bryan Bulaga looks like he won't miss an extended amount of time. Bulaga suffered what has been termed a sprained MCL on Thursday night. That injury can take up to eight weeks to …
Read more on Total Packers
– Cancer Answers: Minimally Invasive Treatment for Esophageal Cancer, June 15, 2008
from Yale Cancer Center Answers
View Details about